Tesamorelin + Ipamorelin Blend Research — Air Transit

For a wholesale buyer, long-distance air transit of tesamorelin and ipamorelin research material comes down to three things you can actually verify: the material travels lyophilized and sealed, the batch documentation identifies and quantifies every active compound in the vial, and the supplier can account for what happened between their dock and your receiving area. A two-peptide blend makes the second of those materially harder, because a single purity figure on a certificate of analysis cannot describe two different molecules at once. Real Peptides lists tesamorelin and ipamorelin as individual compounds with publicly verifiable batch COAs, which is the simpler position to audit when material has been through a long freight lane.

Why the flight is rarely the part that damages material

Lyophilized peptide is a dried amorphous solid. Freeze-drying pulls water out by sublimation and leaves behind a cake with low residual moisture, and that dryness is what suppresses the degradation chemistry peptides are prone to in solution — deamidation at asparagine and glutamine residues, oxidation at methionine, hydrolysis of the backbone, and aggregation. Keep the solid dry and below the temperature at which the amorphous matrix gains molecular mobility, and the molecule largely sits still. Raise the moisture content or the temperature and the same reactions start running, slowly at first, cumulatively over time.

That is why the airborne leg of a shipment is usually not the problem. Cargo holds are variable but bounded, and the transit hours are finite. The exposure that accumulates is ground dwell: the pallet waiting on a tarmac, the sorting facility, the customs queue, the handoff between carriers, the final-mile vehicle. None of those appear on a tracking page as a temperature event, and most buyers never ask about them. A second, less obvious risk is the cold pack itself. Refrigerated or frozen gel packs have a finite effective window, and a shipper that packs for a short domestic lane and then routes the parcel through a long international one can produce partial thaw and refreeze cycles. For some lyophilized material, repeated cycling through a phase change is a worse insult than steady ambient exposure would have been.

Stability profiles differ by compound and by formulation, so the durable rule is to read the storage conditions the supplier states for the specific lot rather than applying a general assumption to every vial on the invoice. Ask what the stated short-term ambient tolerance is, ask what the long-term storage condition is, and ask whether the supplier will document an excursion if one occurs. A supplier who cannot answer those questions for their own product is not going to answer them after a freight delay either.

What a two-peptide blend does to your paperwork

Tesamorelin and ipamorelin are structurally unalike. Tesamorelin is a synthetic analog of growth-hormone-releasing factor, a long chain in the range of a small protein. Ipamorelin is a pentapeptide studied in preclinical literature as a growth hormone secretagogue acting at the ghrelin receptor. Research on both compounds is laboratory work, and nothing here describes use in people. What matters commercially is that two molecules of such different length, mass and hydrophobicity behave differently on an analytical column and degrade along different pathways at different rates.

That creates a verification problem specific to blends. Reversed-phase HPLC purity for a single compound is straightforward to read: one main peak, a stated area percentage, and impurity peaks you can see. Put two actives in one vial and the method has to resolve both, the certificate has to identify which peak is which, and the report has to quantify each component separately rather than reporting one aggregate number. Mass spectrometry confirms identity by molecular weight, which is where a blend COA earns or loses credibility — if the document does not show a confirmed mass for each stated active, you are taking the ratio on trust. Degradation products complicate it further, because a truncated fragment of the longer peptide can elute near the shorter one and inflate what looks like clean material.

The ratio question is the last piece. A blend is labeled by milligrams of each component per vial, and any concentration a researcher derives is simply milligrams per millilitre once the material is in solution. Real Peptides does not provide preparation or use guidance of any kind, because these are research-use-only compounds and that guidance belongs to the qualified investigator and their institutional oversight. What a buyer can reasonably demand is that the stated milligram content per component is supported by an assay result, not just printed on a label. When a supplier cannot produce that, single-compound vials — such as the individually listed Tesamorelin 10mg and Ipamorelin 10mg — remove the ambiguity entirely, because one vial maps to one COA and one purity figure.

Packaging, custody and what happens when a lane goes wrong

Long lanes fail in predictable ways, and the questions worth asking a supplier before you place volume are the ones that only matter after something goes sideways. Start with the physical package: sealed vials with intact crimped seals, tamper-evident secondary containment, and lot or batch identifiers printed on the vial itself rather than only on an outer label that can separate from the goods. If the lot number lives only on a sticker on the box, your traceability ends at the moment someone opens that box.

Then ask about the shipper configuration. Insulated containers and coolant are sized for an expected transit duration, so the relevant question is what duration the supplier packs for and what they do when a lane runs longer. Ask whether they will reship on a documented excursion, who files the carrier claim, and what evidence they require from you to open one. Ask how they handle a delivery that sat unattended at a closed facility over a weekend. These are not exotic scenarios on international freight; they are the normal failure modes, and the difference between suppliers shows up entirely in how they are handled.

Finally, ask about record retention. A supplier who retains batch records and can reissue the COA for a lot you received months ago gives you a defensible paper trail. A supplier whose documentation disappears from their site when the lot sells out does not.

The legal questions that belong to your counsel, not your vendor

This section is informational and is not legal advice. Cross-border and long-distance movement of research chemicals sits in a regulatory space that varies by jurisdiction and changes, and no supplier should be telling you what you are permitted to do. The honest framing is a list of questions to resolve with your own attorney and, where relevant, your state board.

Ask what import, labeling and recordkeeping requirements apply to research-use-only material arriving in your jurisdiction, and whether the research-use-only designation itself changes how the shipment is classified on entry. Ask what your business is permitted to do with the material once it arrives — hold it, resell it, transfer it — and whether your entity type or any license you hold affects that answer. Ask whether carrier terms of service impose their own restrictions independent of law, because carriers set contractual rules that can be stricter than any statute. And treat personal transport as a separate question entirely: moving material yourself on a passenger flight raises carrier, security-screening and customs issues that have nothing in common with commercial freight, and nothing about a commercial shipping arrangement should be read as guidance on that. In most cases the practical answer is that commercial freight with proper documentation is the lane built for this, and anything else needs specific advice before you assume it is available to you.

A verification checklist before you commit volume

What Real Peptides does differently

Real Peptides tests to 99%+ HPLC purity and runs a 7-panel batch test on every production lot, and the resulting certificates of analysis are published for buyers to verify themselves rather than being issued on request or sold separately. That matters most in exactly the scenario this article describes: when material has crossed a long freight lane, the buyer who can pull up the batch record independently is in a different position from the buyer who has to ask permission to see it. Catalog compounds are listed individually, so the purity figure, the batch and the vial correspond one to one with no interpretation required.

Fulfillment is US-based, with orders shipping in 5 to 7 days — a shorter, more predictable domestic lane than a multi-leg international route, with fewer handoffs where custody and temperature records go missing. Pricing tiers and program terms are presented up front rather than held behind a discovery call, which is the practice most worth avoiding in this category alongside unverifiable testing claims and COAs treated as a paid extra. None of these compounds are FDA-approved drugs, none are sold for human consumption, and the research described in the literature is hedged accordingly: studies report findings in laboratory and preclinical settings, and that is the only claim being made.

Qualified businesses apply through a 3-step wholesale application, and approved partners get tier pricing, batch documentation and a single fulfillment path for the compounds they stock.

If your business is building a catalog around growth-factor research compounds and you need documentation that holds up months after delivery, the Wholesale Partner Program application is the next step — it takes a few minutes, and approval gives you access to tier pricing and the full batch record for everything you stock.

For related research reading, the catalog also covers compounds frequently stocked alongside these, including CJC-1295 No DAC 10mg and AOD-9604, and the broader Growth Factor and Tissue Signaling Research collection groups these compounds together for buyers comparing category coverage before applying.

Research Use and Legal Notice

All compounds discussed on this page are sold for research use only and are not for human consumption.